Why is Emmessar Biotech falling/rising?

As of 04-September, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at Rs 26.60, reflecting a decrease of 0.09 or 0.34%. The stock has been underperforming, with a consecutive fall over the last three days resulting in a total decline of 2.35%. It is also trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 3.01% away from Rs 25.8. The delivery volume has decreased by 14.14% compared to the 5-day average, suggesting a drop in investor participation. The stock's performance over various periods shows a significant year-to-date decline of 42.55%, and a one-month drop of 7.99%, further highlighting its struggles.
In the broader market context, the Sensex has shown a positive return of 0.80% over the past week, contrasting sharply with Emmessar Biotech's decline of 4.83% during the same period. This underperformance relative to the benchmark indicates that the stock is not only struggling in isolation but is also lagging behind the overall market trend. The year-to-date performance of the stock is notably poor compared to the Sensex's gain of 3.30%, reinforcing the notion that investor sentiment towards Emmessar Biotech is currently negative.